Who we are
OzempicEdge was built for the millions of Americans navigating GLP-1 medications without a clear, independent guide.
When semaglutide prescriptions surged past 30 million in the US, the internet filled with conflicting information — pharma-funded content, outdated advice, and articles written by people who had never taken these medications. OzempicEdge exists to fix that.
What we do
We publish evidence-based guides on Ozempic, Wegovy, Mounjaro, and other GLP-1 medications — covering everything from getting a prescription affordably to managing side effects, building a sustainable diet, and choosing the right telehealth program.
Every article is researched using peer-reviewed sources, FDA guidance, and real user experiences from the GLP-1 community.
Who runs this site
OzempicEdge is run by Robert, a health researcher and web developer with a background in medical content. This site has no affiliation with any pharmaceutical company, telehealth provider, or insurance company. When we recommend a product or program, we say so clearly and explain why.
Our editorial standards
- All health claims are linked to primary sources (CDC, NIH, FDA, PubMed)
- We disclose all affiliate relationships transparently
- Content is reviewed for accuracy before publication
- We update articles when guidelines or prices change
Contact us
Have a question, correction, or partnership enquiry? Contact us here.